✦ LIBER ✦

Safety and Tolerability of Levomilnacipran ER in Major Depressive Disorder: Results from an Open-Label, 48-Week Extension Study

✍ Scribed by Mago, Rajnish; Forero, Giovanna; Greenberg, William M.; Gommoll, Carl; Chen, Changzheng

Book ID: 121622942
Publisher: Springer International Publishing AG
Year: 2013
Tongue: English
Weight: 288 KB
Volume: 33
Category: Article
ISSN: 1179-1918
DOI: 10.1007/s40261-013-0126-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Erratum to: Safety and Tolerability of L

Erratum to: Safety and Tolerability of Levomilnacipran ER in Major Depressive Disorder: Results from an Open-Label, 48-Week Extension Study

✍ Mago, Rajnish; Forero, Giovanna; Greenberg, William M.; Gommoll, Carl; Chen, Cha 📂 Article 📅 2013 🏛 Springer International Publishing AG 🌐 English ⚖ 137 KB

P.2.b.020 Safety and tolerability of lev

P.2.b.020 Safety and tolerability of levomilnacipran SR in major depressive disorder: results from an open-label, 48-week extension study

✍ Mago, R.; Forero, G.; Greenberg, W.M.; Gommoll, C.; Chen, C. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Efficacy and tolerability of mirtazapine

Efficacy and tolerability of mirtazapine in treating major depressive disorder with anxiety symptoms: an 8-week open-label randomised paroxetine-controlled trial

✍ J. E. Kim; S. J. Yoon; J. Kim; J. Y. Jung; H. S. Jeong; H. B. Cho; E. Shin; I. K 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB

Safety, compliance and the effects on me

Safety, compliance and the effects on memory of 48-week Souvenaid use in mild Alzheimer's disease: Results from the Souvenir II and open-label extension study

✍ Scheltens, Philip; Twisk, Jos; Blesa, Rafael; Scarpini, Elio; von Arnim, Christi 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 73 KB

P.2.f.021 The safety and tolerability of

P.2.f.021 The safety and tolerability of vortioxetine in treating adults with major depressive disorder after 52 weeks of open-label treatment

✍ Baldwin, D.S.; Mahableshwarkar, A.R.; Chrones, L.; Palo, W.; Matz, J. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 59 KB

P01-317 - Safety and tolerability of ari

P01-317 - Safety and tolerability of aripiprazole in the treatment of irritability associated with autistic disorder in pediatric patients: Results from a 52-week open-label study

✍ W. Landsberg; J.-Y. Loze; G. Lau; G. Manos; R. McQuade; L. Kamen; R. Marcus; R. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 French ⚖ 31 KB